Crossover Study to Compare the Pharmacokinetics of Subcutaneous and Intravenous Ceftriaxone Administration

NCT02561442 · clinicaltrials.gov ↗
PHASE2,PHASE3
Phase
COMPLETED
Status
18
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

scPharmaceuticals, Inc.